FDA
-
-
-
-
-
-
-
Axsome Therapeutics Settles SUNOSIĀ® (solriamfetol) Patent Litigation with Alkem Laboratories Ltd.
-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) PT Raised to $200 at H.C. Wainwright
-
-
-
-
-
-
-
TD Cowen on Axsome Therapeutics (AXSM): 'the sNDA acceptance should be well received by investors'
-
-
-
-
-
-
-
Axsome Therapeutics acquires epilepsy drug candidate from AstraZeneca
-
-
-
-
-
-
-
RBC Capital on Biotech: 'Who Wins and Who Loses If RFK, Jr. Goes'
-
-
-
-
-
-
-
Axsome Therapeutics Hosts Frontiers in Brain Health R&D Day Reviewing Industry-Leading Late-Stage CNS Pipeline
-
-
-
-
-
-
-
Axsome Therapeutics Champions Brain Health During Alzheimer's & Brain Awareness Month
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

